Compare Lowe`s Companies Inc (LOW) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lowe`s Companies Inc vs Zimmer Biomet Holdings Inc — how do they compare? Lowe`s Companies Inc trades at $203 (market cap $114.78B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Lowe`s Companies Inc is far larger — about 6.6× Zimmer Biomet Holdings Inc's market cap, and Lowe`s Companies Inc pays the higher dividend (2.44%). Which is the better fit depends on your goals.
| LOW | ZBH | |
|---|---|---|
Market Cap | $114.78B | $17.36B |
Sector | Consumer Cyclical | Health |
52-Week High | $287.39 | $107.71 |
52-Week Low | $204.76 | $79.58 |
Enterprise Value | $156.54B | $24.40B |
Dividend Yield | 2.44% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lowe's Companies (LOW) trades at $203.52, down 2.5% over the past day, amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS expected at $4.26. Revenue declined to $83.67 billion in 2025, but net income margin remains healthy at 7.51%. Analyst consensus is strongly bullish with a $260.88 price target, though technical indicators show selling pressure and support near $196.
LOW presents a mixed outlook: strong fundamentals and analyst support contrast with near-term technical weakness. Upside potential exists if earnings momentum continues and interest rate declines benefit home improvement spending. Key risks include revenue volatility, high debt levels, and competitive pressures. The stock's current dip may offer a buying opportunity for long-term investors, contingent on macroeconomic stability.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
